What are the potential benefits and risks of using anabolic therapies in frail patients with osteoporosis?
Anabolic therapies, including teriparatide, abaloparatide, and romosozumab, significantly reduce fracture risk and increase BMD in frail patients with osteoporosis but require careful cardiovascular risk assessment and consideration of cost and treatment accessibility.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24367212
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00